Proliferation dangers associated with nuclear medicine
Getting weapons-grade uranium out of radiopharmaceutical production
Bibliographic Data
| ID | 19503443 |
|---|---|
| Authors | Bill Williams (0000-0003-1604-748X), Tilman Ruff (0000-0001-9823-3918, The University of Melbourne, corresponding author), Tilman A Ruff |
| Year | 2007 |
| Volume | 23 |
| Issue | 4 |
| Pages | 267-281 |
| Publication date | 2007-10-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medicine Conflict & Survival (JOURNAL) |
| Journal identifiers | ISSN: 1362-3699 • E-ISSN: 1743-9396 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/13623690701596692 |
| PMID | 17987979 |
| OpenAlex | W2109596153 |
| Language | EN |
| References cited | 9 |
Abolishing the threat of nuclear war requires the outlawing of nuclear weapons and dismantling current nuclear weapon stockpiles, but also depends on eliminating access to fissile material (nuclear weapon fuel). The near-universal use of weapons-grade, highly enriched uranium (HEU) to produce radiopharmaceuticals is a significant proliferation hazard. Health professionals have a strategic opportunity and obligation to progress the elimination of medically-related commerce in HEU, closing one of the most vulnerable pathways to the much-feared 'terrorist bomb'
Nuclear physics · Nuclear weapon · Physics · Radiochemistry · Uranium · Chemistry · Medicine · Nuclear and radioactivity studies · Nuclear Issues and Defense · Radioactive contamination and transfer
| Citation velocity | historical |
|---|---|
| Highly cited | No |